Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial von Georgoulias, Vassilis, Androulakis, Nikolaos, Kotsakis, Athanasios, Hatzidaki, Dora, Syrigos, Kostas, Polyzos, Aris, Agelidou, Athina, Varthalitis, Ioannis, Ziras, Nikoalos, Agelidou, Maria, Chandrinos, Vassilis, Boukovinas, Ioannis, Geroyianni, Alexandra, Vamvakas, Lambros, Mavroudis, Dimitris

Volltext